Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Victrex ( (GB:VCT) ) has provided an update.
Victrex plc has confirmed that, as of 30 January 2026, its issued share capital comprises 87,072,680 ordinary shares of 1p each, with every share carrying one voting right and no shares held in treasury. This update sets the total number of voting rights at 87,072,680, providing investors and other stakeholders with the denominator needed to assess and disclose any notifiable holdings or changes in their interest under regulatory transparency rules, thereby supporting more accurate monitoring of ownership and compliance with UK market disclosure requirements.
The most recent analyst rating on (GB:VCT) stock is a Hold with a £710.00 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Spark’s Take on GB:VCT Stock
According to Spark, TipRanks’ AI Analyst, GB:VCT is a Outperform.
Victrex’s overall stock score reflects a stable financial position with strong equity and low leverage. Technical indicators suggest short-term bullish momentum, while valuation is favorable with a high dividend yield. However, challenges in revenue growth, profitability, and recent earnings call concerns weigh on the score.
To see Spark’s full report on GB:VCT stock, click here.
More about Victrex
Victrex plc is a UK-listed specialty chemicals company, known for its high-performance polymer solutions and advanced materials used across industrial, automotive, aerospace, electronics and other high-specification markets. The company focuses on engineering polymers that serve global manufacturers requiring lightweight, durable and high-temperature-resistant materials.
Average Trading Volume: 329,518
Technical Sentiment Signal: Sell
Current Market Cap: £639.6M
For detailed information about VCT stock, go to TipRanks’ Stock Analysis page.

